EDAP
Edap Tms S.a.NASDAQHealthcare$3.39-3.97%ClosedMarket Cap: $127.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
6.79
P/S
1.72
EV/EBITDA
-5.63
DCF Value
$-63.33
FCF Yield
-18.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
46.1%
Operating Margin
-38.6%
Net Margin
-44.9%
ROE
-114.9%
ROA
-37.1%
ROIC
-63.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $21.9M | 36.9% | $-8.5M | $-11.6M | $-0.25 | — |
| FY 2025 | $70.7M | 42.5% | $-25.2M | $-29.3M | $-0.69 | — |
| Q3 2025 | $13.9M | 43.0% | $-4.9M | $-5.0M | $-0.13 | — |
| Q2 2025 | $16.0M | 42.5% | $-5.8M | $-5.6M | $-0.15 | — |
| Q1 2025 | $13.6M | 42.0% | $-6.0M | $-7.1M | $-0.19 | — |
| Q4 2024 | $20.3M | 44.8% | $-3.7M | $-1.9M | $-0.05 | — |
| FY 2024 | $64.1M | 41.4% | $-20.5M | $-19.0M | $-0.51 | — |
| Q3 2024 | $13.1M | 39.4% | $-5.8M | $-6.4M | $-0.17 | — |
| Q2 2024 | $15.8M | 37.5% | $-6.1M | $-6.1M | $-0.17 | — |
| Q1 2024 | $14.9M | 42.8% | $-4.8M | $-4.5M | $-0.12 | — |
| Q4 2023 | $19.6M | 43.7% | $-3.5M | $-5.0M | $-0.14 | — |
| FY 2023 | $60.4M | 40.4% | $-19.8M | $-21.2M | $-0.57 | — |